In last trading session, Biodesix Inc. (NASDAQ:BDSX) saw 0.2 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $1.50 trading at $0.02 or 1.35% at ring of the bell on the day assigns it a market valuation of $64.06M. That closing price of BDSX’s stock is at a discount of -380.0% from its 52-week high price of $7.20 and is indicating a premium of 36.67% from its 52-week low price of $0.95. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.32 million shares which gives us an average trading volume of 191.76K if we extend that period to 3-months.
Biodesix Inc. (NASDAQ:BDSX) trade information
Upright in the green during last session for gaining 1.35%, in the last five days BDSX remained trading in the green while hitting it’s week-highest on Tuesday, 11/22/22 when the stock touched $1.50 price level, adding 4.46% to its value on the day. Biodesix Inc.’s shares saw a change of -71.64% in year-to-date performance and have moved 30.43% in past 5-day. Biodesix Inc. (NASDAQ:BDSX) showed a performance of 44.23% in past 30-days. Number of shares sold short was 0.23 million shares which calculate 1.9 days to cover the short interests.
Biodesix Inc. (BDSX) estimates and forecasts
Statistics highlight that Biodesix Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company added 7.91% of value to its shares in past 6 months, showing an annual growth rate of 3.80% while that of industry is 3.60. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 19.50% in the current quarter and calculating 40.80% increase in the next quarter. This year revenue growth is estimated to fall -28.70% from the last financial year’s standing.
3 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $10.17 million for the same. And 3 analysts are in estimates of company making revenue of $11.3 million in the next quarter that will end on Dec 2022. Company posted $6.17 million and $7.22 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 64.80% while estimating it to be 56.40% for the next quarter.
Biodesix Inc. is more likely to be releasing its next quarterly report on November 03 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Biodesix Inc. (NASDAQ:BDSX)’s Major holders
Insiders are in possession of 68.25% of company’s total shares while institution are holding 9.27 percent of that, with stock having share float percentage of 29.19%. Investors also watch the number of corporate investors in a company very closely, which is 9.27% institutions for Biodesix Inc. that are currently holding shares of the company. Birchview Capital, LP is the top institutional holder at BDSX for having 1.81 million shares of worth $2.97 million. And as of Jun 29, 2022, it was holding 4.53% of the company’s outstanding shares.
The second largest institutional holder is Wells Fargo & Company, which was holding about 0.55 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 1.37% of outstanding shares, having a total worth of $0.9 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 0.11 million shares of worth $0.18 million or 0.27% of the total outstanding shares. The later fund manager was in possession of 69032.0 shares on Jun 29, 2022, making its stake of worth around $0.11 million in the company or a holder of 0.17% of company’s stock.